It is noteworthy that accumulating research suggests a link between the dysregulation of plasma kallikrein (PKa) and the progression of various carcinomas, including lung [21], pancreatic [22], colorectal [23], and breast [24] cancers. This evidence concerns the gene KLK4 and carcinoma.